BD Intraosseous Infusion System

BD Intraosseous Infusion System is an FDA 510(k)-cleared medical device (K203193) manufactured by Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]. This device is classified under the General Hospital specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 3, 2021. Regulation: 8.